Assessment of Hemodynamic Response in Cardiopulmonary Bypass Graft After Cardiopulmonary Bypass Using Transesophegeal Echocardiography

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a double blind randomization study, assessing hemodynamic response in patients who underwent a cardiopulmonary bypass graft (CABG) with cardiopulmonary bypass (CPB) using intraoperative trasnesophageal echocardiography (TEE) to know what inotropic drug will be batter to improve the heart function. Epinephrine, milrinone, dobutamine and levosimendan will be assessment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Federal University of Juiz de Fora
• Collaborators: National Institute of Cardiology/Ministry of Health; Universidade Federal do Rio de Janeiro
• Treatments: Epinephrine; Epinephryl borate; Racepinephrine; Simendan

Criteria

Inclusion Criteria:

• Sinusal ritmus

• EF > 35%

• Elective CABG surgery

Exclusion Criteria:

• No accept

• Severe valvular regurgitation or stenoses

• Chest pain

• Cardiogenic shock